https://alsnewstoday.com/news/european-approval-amx0035-als-faces-new-hurdle-review/
0
0
38 words
0
Comments
The CHMP has asked Amylyx Pharmaceuticals to go through a second round of questions as part of the regulatory process for AMX0035 for ALS.
You are the first to view
Create an account or login to join the discussion